Cód QR

Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study

Abstract Background Soluble urokinase plasminogen activator receptor is an inflammatory biomarker that may prognosticate cardiovascular outcomes. We sought to determine the associations between soluble urokinase plasminogen activator receptor and established markers of cardiotoxicity in breast cance...

Cur síos iomlán

Sábháilte in:
Príomhchruthaitheoirí: Jian Chu, Lillian Tung, Issam Atallah, Changli Wei, Melody Cobleigh, Ruta Rao, Steven B. Feinstein, Lydia Usha, Kathrin Banach, Jochen Reiser, Tochukwu M. Okwuosa
Formáid: Artigo
Teanga:Inglês
Foilsithe / Cruthaithe: BMC 2024-01-01
Sraith:Cardio-Oncology
Ábhair:
Soluble urokinase Plasminogen Activator Receptor (suPAR)
Biomarker
Global longitudinal strain (GLS)
Echocardiography
B-type natriuretic peptide (BNP)
Troponin
Rochtain ar líne:https://doi.org/10.1186/s40959-023-00191-0
Clibeanna: Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!

Míreanna comhchosúla